Utilization of preoperative endoscopic ultrasound for pancreatic adenocarcinoma.

ABSTRACT:

Background

Endoscopic ultrasound (EUS) is used for pancreatic adenocarcinoma staging and obtaining a tissue diagnosis. The objective was to determine patterns of preoperative EUS and the impact on downstream treatment.

Methods

The Surveillance, Epidemiology, and End Results (SEER) Medicare-linked database was used to identify patients with pancreatic adenocarcinoma. The staging period was the first staging procedure within 6 months of surgery until surgery. Logistic regression was used to determine factors associated with preoperative EUS. The main outcome was EUS in the staging period, with secondary outcomes including number of staging tests and time to surgery.

Results

2782 patients were included, 56% were treated at an academic hospital (n = 1563). 1204 patients u

SUBMITTER: Schmocker RK 

PROVIDER: S-EPMC5695546 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature